sábado, 16 de septiembre de 2023

NCI clinical trial leads to atezolizumab approval for advanced alveolar soft part sarcoma

https://www.cancer.gov/news-events/press-releases/2022/nci-trial-atezolizumab-approval-alveolar-soft-part-sarcoma

No hay comentarios:

Publicar un comentario